Actively Recruiting
Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)
Led by Fundacion Clinic per a la Recerca Biomédica · Updated on 2025-12-18
140
Participants Needed
1
Research Sites
79 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.
CONDITIONS
Official Title
Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients on the official liver transplant waiting list
- Hemoglobin level 11.5 g/dL or lower
- Women of child-bearing potential must have a negative serum pregnancy test before joining and agree to use highly effective contraception methods during the study, excluding hormonal contraceptives
You will not qualify if you...
- Acute or subacute liver failure
- Acute-on-chronic liver failure grade III or MELD score above 35
- History of thrombosis, including portal vein thrombosis
- Significant coronary artery disease needing angioplasty or stents
- Serum ferritin over 800 ng/mL and saturation over 50%
- Use of anticoagulant or antiplatelet therapy
- History of seizures
- Uncontrolled hypertension requiring two or more medications
- Active infection or sepsis
- Lack of patient consent
- Pregnancy or breastfeeding
- Participation in another clinical trial within the past month
- Mental incapacity, language barrier, poor social support, or other reasons preventing adequate study compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain, 08036
Actively Recruiting
Research Team
A
Anna cruceta, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here